Vol. 3, Issue 7 (2014)

Materials and Methods: For the aforementioned study, 80 patients of either sex were enrolled and randomly assigned. It was an open, prospective, single-blind, randomised clinical experiment. It was conducted from July 2013 to August 2014 at Department of Dermatology, Maharajah’s Institute of Medical Sciences, Nellimarla, Vizianagaram, Andhra Pradesh, India.

Results: There was a larger decrease in both inflammatory and non-inflammatory acne lesions, and patients in this group had a moderate to good response. After 4 weeks, acne lesions had reduced by 25% and by 8 weeks, they had reduced by 60%. A moderate to good response was noted at the conclusion of the 12-week therapy period, with a reduction of 80.3%. Only a small percentage of participants experienced the potential side effects, which included skin peeling, redness, irritation, dryness, and itching. In comparison to topical 0.1% tazarotene cream, their side effects were minor and short-lived. Both patient compliance and treatment outcomes were positively impacted by the topical 0.1% adaplene cream. Regular and proper care was provided by patients.

Conclusion: Acne vulgaris was more common in men than females in this study. In both sexes, the incidence was highest in those between the ages of 15 and 20. Acne vulgaris was found to be quite common among students in this study.